TLGT News and Press, Teligent Inc. From 10/31/19

BUENA, N.J., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced they will hold a conference call at 4:30pm ET on Monday November 4 th , 2019 to discuss the 3 rd quarter 2019 financial results and business ...

Background 1035 Capital recently wrote an article on TLGT highlighting the underappreciated value of this turnaround generic manufacturer. As we predicted, there has been significant volatility in the share price. Since publication on Aug 8th, the price spiked up to ~$1.10 and has recen...

BUENA, N.J., Oct. 28, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced the pricing of $34,405,000 aggregate principal amount of its 7.0% Cash / 8...

BUENA, N.J., Oct. 28, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced that it has filed a prior approval supplement (PAS) for ranitidine hydrochloride injection. This is the planned first injectable product...

BUENA, N.J., Oct. 18, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration (FDA...

Teligent (NASDAQ: TLGT ) is up 4.4% postmarket after it announced it's hired advisers to assist with a strategic review of assets . More news on: Teligent, Inc., Healthcare stocks news, Stocks on the move, Read more ...

BUENA, N.J., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Teligent Inc. (Nasdaq: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced that it has retained SVB Leerink as its financial advisor to assist with a strategic review of assets non-core to the Company’s lo...

Editor's note: Seeking Alpha is proud to welcome 1035 Capital Management as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA Essential. Click here to find out more » Backgr...

Teligent, Inc. (TLGT) Q2 2019 Earnings Conference Call August 5, 2019 4:30 PM ET Company Participants Jason Grenfell-Gardner – President and Chief Executive Officer Damian Finio – Chief Financial Officer Conference Call Participants Matt Hewitt – Craig-Ha...

Teligent (NASDAQ: TLGT ): Q2 Non-GAAP EPS of -$0.04 in-line; GAAP EPS of -$0.08 beats by $0.03 . More news on: Teligent, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...